Institutional Ownership Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX). We have compiled data on the 654 institutions that hold shares in the stock, with a total of 96.5 Million shares, which have been reported (via 13F filing form) to have a value of $11.5 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
14,190,708
shares
|
$1.69 Billion
0.04% of portfolio
|
Q2 2024
Added 3.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
10,119,641
shares
|
$1.21 Billion
0.02% of portfolio
|
Q4 2024
Added 1.23%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,891,137
shares
|
$583 Million
0.03% of portfolio
|
Q4 2024
Reduced 4.99%
|
|
|
Dodge & Cox
San Francisco, CA |
Feb 13, 2025 Q4 2024 |
3,016,425
shares
|
$359 Million
0.26% of portfolio
|
Q4 2024
Added 134.23%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,538,109
shares
|
$302 Million
0.06% of portfolio
|
Q4 2024
Added 43.84%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
2,489,397
shares
|
$297 Million
0.54% of portfolio
|
Q4 2024
Reduced 3.31%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,896,891
shares
|
$226 Million
0.34% of portfolio
|
Q4 2024
Added 2.91%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,875,062
shares
|
$223 Million
0.02% of portfolio
|
Q4 2024
Added 0.85%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
1,820,000
shares
|
$217 Million
4.95% of portfolio
|
Q4 2024
Reduced 2.35%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,573,297
shares
|
$187 Million
0.02% of portfolio
|
Q4 2024
Added 16.59%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,490,513
shares
|
$178 Million
0.02% of portfolio
|
Q4 2024
Reduced 11.02%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,457,425
shares
|
$174 Million
0.04% of portfolio
|
Q4 2024
Added 102.92%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,371,186
shares
|
$163 Million
0.02% of portfolio
|
Q4 2024
Reduced 8.46%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
1,347,820
shares
|
$161 Million
0.21% of portfolio
|
Q3 2022
Reduced 8.29%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,070,096
shares
|
$127 Million
0.03% of portfolio
|
Q4 2024
Added 19.67%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
983,799
shares
|
$117 Million
0.02% of portfolio
|
Q4 2024
Reduced 3.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
981,939
shares
|
$117 Million
0.02% of portfolio
|
Q4 2024
Added 27.26%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
949,512
shares
|
$113 Million
0.03% of portfolio
|
Q4 2024
Added 8.56%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Feb 11, 2025 Q4 2024 |
944,738
shares
|
$113 Million
0.32% of portfolio
|
Q4 2024
Added 15.22%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
938,120
shares
|
$112 Million
3.47% of portfolio
|
Q4 2024
Added 210.41%
|
|
|
Dsm Capital Partners LLC
Palm Beach Gardens, FL |
Jan 31, 2025 Q4 2024 |
932,595
shares
|
$111 Million
2.21% of portfolio
|
Q4 2024
Reduced 1.22%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
924,416
shares
|
$110 Million
0.1% of portfolio
|
Q2 2023
Added 27.64%
|
|
|
Braidwell LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
901,790
shares
|
$107 Million
6.9% of portfolio
|
Q4 2024
Reduced 1.73%
|
|
|
Brown Advisory Inc
|
Feb 14, 2025 Q4 2024 |
898,293
shares
|
$107 Million
0.16% of portfolio
|
Q4 2024
Reduced 4.65%
|
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
892,000
shares
|
$106 Million
1.72% of portfolio
|
Q4 2024
Added 391.78%
|